These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7737248)

  • 21. [Corticobasal degeneration: symptomatological, brain-imaging and electrophysiological studies].
    Morimatsu M; Negoro K
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1459-62. PubMed ID: 8752430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SPECT data in a case of secondary Capgras delusion.
    Lebert F; Pasquier F; Steinling M; Cabaret M; Caparros-Lefebvre D; Petit H
    Psychopathology; 1994; 27(3-5):211-4. PubMed ID: 7846239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patterns of regional cerebral blood flow in corticobasal degeneration studied using HMPAO SPECT; comparison with Parkinson's disease and normal controls.
    Markus HS; Lees AJ; Lennox G; Marsden CD; Costa DC
    Mov Disord; 1995 Mar; 10(2):179-87. PubMed ID: 7753060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatic encephalopathy with increased cerebral blood flow in SPECT and MRI abnormalities in the basal ganglia.
    Kohira I; Matsuo E; Shiro Y; Uemura N; Matsumoto S; Kitamura Y; Matsumoto Y; Ishizu H; Sakai K; Kuroda S
    Jpn J Psychiatry Neurol; 1994 Mar; 48(1):33-6. PubMed ID: 7933713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cerebral blood flow in corticobasal degeneration.
    Okuda B; Tachibana H
    Mov Disord; 1995 Nov; 10(6):803. PubMed ID: 8750006
    [No Abstract]   [Full Text] [Related]  

  • 26. [Cerebral SPECT with iodine-123 IBZM in patients with extrapyramidal system disorders: the evaluation of its sensitivity in therapy with dopaminergic drugs].
    Hierholzer J; Castelli L; Cordes M; Schelosky L; Poewe W; Felix R
    Radiol Med; 1996 Mar; 91(3):207-10. PubMed ID: 8628932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Limb-kinetic apraxia.
    Denes G; Mantovan MC; Gallana A; Cappelletti JY
    Mov Disord; 1998 May; 13(3):468-76. PubMed ID: 9613739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The metabolic landscape of cortico-basal ganglionic degeneration: regional asymmetries studied with positron emission tomography.
    Eidelberg D; Dhawan V; Moeller JR; Sidtis JJ; Ginos JZ; Strother SC; Cederbaum J; Greene P; Fahn S; Powers JM
    J Neurol Neurosurg Psychiatry; 1991 Oct; 54(10):856-62. PubMed ID: 1744638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical features of corticobasal degeneration].
    Farsang M; Takáts A; Szirmai I; Kovács T
    Ideggyogy Sz; 2005 Jan; 58(1-2):45-51. PubMed ID: 15884398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Corticobasal degeneration and frontotemporal dementia presentations in a kindred with nonspecific histopathology.
    Boeve BF; Maraganore DM; Parisi JE; Ivnik RJ; Westmoreland BF; Dickson DW; Hutton M; Hardy J; Caselli RJ; Petersen RC
    Dement Geriatr Cogn Disord; 2002; 13(2):80-90. PubMed ID: 11844889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopamine D2 receptor imaging and measurement with SPECT.
    Brücke T; Wenger S; Asenbaum S; Fertl E; Pfafflmeyer N; Müller C; Podreka I; Angelberger P
    Adv Neurol; 1993; 60():494-500. PubMed ID: 8420177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebral Glucose Metabolism and Dopaminergic Function in Patients with Corticobasal Syndrome.
    Mille E; Levin J; Brendel M; Zach C; Barthel H; Sabri O; Bötzel K; Bartenstein P; Danek A; Rominger A
    J Neuroimaging; 2017 Mar; 27(2):255-261. PubMed ID: 27572945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional imaging studies in corticobasal degeneration.
    Brooks DJ
    Adv Neurol; 2000; 82():209-15. PubMed ID: 10624484
    [No Abstract]   [Full Text] [Related]  

  • 34. [123]IBZM binding predicts dopaminergic responsiveness in patients with parkinsonism and previous dopaminomimetic therapy.
    Schwarz J; Tatsch K; Gasser T; Arnold G; Oertel WH
    Mov Disord; 1997 Nov; 12(6):898-902. PubMed ID: 9399212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The eye of the tiger sign in cortical-basal ganglionic degeneration.
    Molinuevo JL; Muñoz E; Valldeoriola F; Tolosa E
    Mov Disord; 1999 Jan; 14(1):169-71. PubMed ID: 9918367
    [No Abstract]   [Full Text] [Related]  

  • 36. 123I-beta-CIT and 123I-IBZM-SPECT scanning in levodopa-naive Parkinson's disease.
    Wenning GK; Donnemiller E; Granata R; Riccabona G; Poewe W
    Mov Disord; 1998 May; 13(3):438-45. PubMed ID: 9613734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of [123I]IBZM pinhole SPECT for the detection of striatal dopamine D2 receptor availability in rats.
    Scherfler C; Scholz SW; Donnemiller E; Decristoforo C; Oberladstätter M; Stefanova N; Diederen E; Virgolini I; Poewe W; Wenning GK
    Neuroimage; 2005 Feb; 24(3):822-31. PubMed ID: 15652317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopamine D1 and D2 receptors in Parkinson's disease and striatonigral degeneration determined by PET.
    Shinotoh H; Hirayama K; Tateno Y
    Adv Neurol; 1993; 60():488-93. PubMed ID: 8420176
    [No Abstract]   [Full Text] [Related]  

  • 39. Iodine-123-iodobenzamide SPECT assessment of dopamine D2 receptor occupancy in riperidone-treated schizophrenic patients.
    Dresel S; Tatsch K; Dähne I; Mager T; Scherer J; Hahn K
    J Nucl Med; 1998 Jul; 39(7):1138-42. PubMed ID: 9669383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lateralized differences in iodine-123-IBZM uptake in the basal ganglia in asymmetric Parkinson's disease.
    Knable MB; Jones DW; Coppola R; Hyde TM; Lee KS; Gorey J; Weinberger DR
    J Nucl Med; 1995 Jul; 36(7):1216-25. PubMed ID: 7790947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.